$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Method for administering fibroblast growth factor to the brain 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/00
  • C07K-005/00
  • C07K-007/00
출원번호 US-0374675 (1999-08-16)
발명자 / 주소
  • William H. Frey, II
출원인 / 주소
  • Chiron Corporation
대리인 / 주소
    W. Murray Spruill
인용정보 피인용 횟수 : 27  인용 특허 : 16

초록

Disclosed is a method for transporting neurologic therapeutic agents to the brain by means of the olfactory neural pathway and a pharmaceutical composition useful in the treatment of brain disorders.

대표청구항

1. A method for transporting a fibroblast growth factor to the brain of a mammal, comprising:applying a pharmaceutical composition comprising the fibroblast growth factor to an upper third of a nasal cavity of the mammal, wherein the fibroblast growth factor is absorbed through a nasal mucosa and tr

이 특허에 인용된 특허 (16)

  1. Knauf Suzanne (Fairport NY), Antigen derived from human ovarian tumors and radioimmunoassay using the antigen.
  2. Bodor Nicholas S. (Gainesville FL), Brain-specific drug delivery.
  3. Pardridge William M. (Pacific Palisades CA) Schimmel Paul R. (Lexington MA), Chimeric peptides for neuropeptide delivery through the blood-brain barrier.
  4. Pardridge William M. (Van Nuys CA), Chimeric peptides for neuropeptide delivery through the blood-brain barrier.
  5. Gibby Wendell A. (7025 N. Via Assisi Tucson AZ 85704), Contrast enhancing agents for magnetic resonance images.
  6. Carey Martin C. (Wellesley MA) Moses Alan C. (Waban MA) Flier Jeffrey S. (West Newton MA), Drug administration.
  7. David Gary S. (La Jolla CA) Greene Howard E. (Carlsbad CA), Immunometric assays using monoclonal antibodies.
  8. della Valle Francesco (Padova ITX) Romeo Aurelio (Rome ITX), Kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical composi.
  9. Arai Motoharu (Tokyo JPX) Ito Masatsugu (Tokyo JPX), Lipid powder having cross-linked coating thereon and process for preparing same.
  10. Yiournas Costas (Vineland NJ) Wallach Donald F. H. (Brookline MA), Method and apparatus for producing lipid vesicles.
  11. Frey ; II William H. (North Oaks MN), Method for administering neurologic agents to the brain.
  12. Pukel Clifford S. (Flushing NY) Lloyd Kenneth O. (Bronx NY) Travassos Luiz R. (Sao Palo BRX) Dippold Wolfgang G. (Mainz CT DEX) Oettgen Herbert F. (New Canaan CT) Old Lloyd J. (New York NY), Method for detecting the presence of GD3 ganglioside.
  13. Reisfeld Ralph A. (La Jolla CA) Schulz Gregor (San Diego CA), Monoclonal antibody directed to human ganglioside GD2.
  14. Seckinger Karl (Riegel DEX), N′-[4-(1-Fluoromethyl-ethyl)phenyl]-urea derivatives.
  15. Glenner George G. (La Jolla CA) Wong Caine W. (Cardiff CA), Polypeptide marker for Alzheimer\s disease and its use for diagnosis.
  16. Suzuki Yoshiki (Tokyo JPX) Sekine Kunio (Tokyo JPX) Nagai Tsuneji (Tokyo JPX) Nambu Naoki (Kanagawa JPX) Nishimoto Yuji (Tokyo JPX), Powdery pharmaceutical composition for nasal administration.

이 특허를 인용한 특허 (27)

  1. Akil, Huda; Bunney, Jr., William E.; Choudary, Prabhakara V.; Evans, Simon J.; Jones, Edward G.; Li, Jun; Lopez, Juan F.; Lyons, David M.; Molnar, Margherita; Myers, Richard M.; Schatzberg, Alan F.; Stein, Richard; Thompson, Robert C.; Tomita, Hiroaki; Vawter, Marquis P.; Watson, Stanley J., Administration of FGF2 for treamtent of anxiety.
  2. Akil, Huda; Watson, Stanley J.; Turner, Cortney, Administration of FGF9 for treatment and prevention of major depression.
  3. Akil, Huda; Watson, Stanley J.; Turner, Cortney, Administration of FGF9 for treatment of anxiety.
  4. Wolf, Daniel A.; Frey, II, William H.; McIvor, R. Scott; Hanson, Leah R., Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases.
  5. Yeomans, David C.; Carson, Dean; Thirucote, Ramachandran, Magnesium-containing oxytocin formulations and methods of use.
  6. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Method of pre-treating patients for stroke comprising administering metal chelators to the upper one-third of the nasal cavity.
  7. Frey, II, William H.; Panter, Samuel Scott; Hanson, Leah Ranae Bresin; Roeytenberg, Annina, Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity.
  8. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Method of treating cerebral hemorrhage and subarachnoid hemorrhage comprising administering metal chelators to the upper one-third of the nasal cavity.
  9. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Method of treating lewy body syndrome comprising administering metal chelators to the upper one-third of the nasal cavity.
  10. Hanson, II, Leah Ranae Bresin; Frey, William H.; Panter, Samuel Scott, Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity.
  11. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Method of treating progressive supranuclear palsy comprising administering metal chelators to the upper one-third of the nasal cavity.
  12. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Method of treating spinal cord injury comprising administering metal chelators to the upper one-third of the nasal cavity.
  13. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavity.
  14. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Method of treating traumatic brain injury/head injury comprising administering metal chelators to the upper one-third of the nasal cavity.
  15. Harmon, Brendan; Waszczak, Barbara Lee; Cooper, Mark, Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders.
  16. Frey, II, William H., Methods for preventing and treating post-traumatic stress disorder (PTSD).
  17. Akil, Huda; Watson, Stanley J.; Turner, Cortney; Bunny, William E.; Jones, Edward G.; Myers, Richard M.; Schatzberg, Alan F., Methods for treating depression using NCAM peptide mimetics.
  18. Yeomans, David C.; Angst, Martin S.; Frey, II, William H.; Jacobs, Daniel I., Methods for treatment of headaches by administration of oxytocin.
  19. Yeomans, David C.; Angst, Martin S.; Frey, II, William H.; Jacobs, Daniel I., Methods for treatment of headaches by administration of oxytocin.
  20. Yeomans, David C.; Angst, Martin S.; Frey, II, William H.; Jacobs, Daniel I., Methods for treatment of headaches by administration of oxytocin.
  21. Yeomans, David C.; Angst, Martin S.; Frey, II, William H.; Jacobs, Daniel I., Methods for treatment of headaches by administration of oxytocin.
  22. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity.
  23. Frey, II, William H.; Panter, Samuel Scott; Bresin Hanson, Leah Ranae, Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavity.
  24. McIvor, R. Scott; Belur, Lalitha R.; Low, Walter; Fairbanks, Carolyn; Kozarsky, Karen, Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase.
  25. Digicaylioglu,Murat; Lipton,Stuart A., Neuroprotective synergy of erythropoietin and insulin-like growth factors.
  26. Abdel Maksoud, Yaser A.; Maher, Mustafa A., Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders.
  27. Yeomans, David C.; Frey, II, William H.; Jacobs, Daniel I.; Angst, Martin S., Therapy procedure for drug delivery for trigeminal pain.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로